Form 4 for IT Gartner
Accepted 2024-11-13 00:00:00 ET · period of report 2024-11-08 · accession 0001127602-24-027230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-13 | 2024-11-08 | IT | Safian Craig | EVP, CFO | M - OptEx | $154.31 | +10.0K | 81.5K | +14% | +$1.54M |
| D | 2024-11-13 | 2024-11-08 | IT | Safian Craig | EVP, CFO | G - Gift | $0.00 | -550 | 74.5K | -0.7% | $0 |
| D | 2024-11-13 | 2024-11-08 | IT | Safian Craig | EVP, CFO | F - Tax | $547.40 | -3,665 | 75.1K | -5% | -$2.01M |
| D | 2024-11-13 | 2024-11-11 | IT | Safian Craig | EVP, CFO | S - Sale+OE | $550.81 | -3,516 | 71.0K | -5% | -$1.94M |
| D | 2024-11-13 | 2024-11-08 | IT | Safian Craig | EVP, CFO | D - Sale to Iss | $547.40 | -2,819 | 78.7K | -3% | -$1.54M |
| D | 2024-11-13 | 2024-11-08 | IT | Safian Craig | EVP, CFO | M - OptEx | $0.00 | -10.0K | 10.7K | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-08 | M | A | 10,000 | $154.31 | 81,550 | D | — | — | (F1) Represents shares acquired upon exercise of SARs. |
| 2 | Common | Common Stock | 2024-11-08 | G | D | 550 | $0.00 | 74,516 | D | — | — | (F4) On November 8, 2024, the reporting person donated 550 shares to a donor-advised fund. |
| 3 | Common | Common Stock | 2024-11-08 | F | D | 3,665 | $547.40 | 75,066 | D | — | — | (F3) Represents shares withheld for the payment of applicable income and payroll withholding taxes. |
| 4 | Common | Common Stock | 2024-11-11 | S | D | 3,516 | $550.81 | 71,000 | D | — | — | |
| 5 | Common | Common Stock | 2024-11-08 | D | D | 2,819 | $547.40 | 78,731 | D | — | — | (F2) Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs. |
| 6 | Derivative | Stock Appreciation Rights | 2024-11-08 | M | D | 10,000 | $0.00 | 10,657 | D | $154.31 · 2021-02-05 to 2027-02-05 | 10,000 Common Stock | (F5) These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 5, 2021, and are fully exercisable. |